Efficacy and safety of intravenous immunoglobulin with rituximab versus rituximab alone in childhood-onset steroid-dependent and frequently relapsing nephrotic syndrome: protocol for a multicentre randomised controlled trial

INTRODUCTION: Guidelines for the treatment of steroid-dependent nephrotic syndrome (SDNS) and frequently relapsing nephrotic syndrome (FRNS) are lacking. Given the substantial impact of SDNS/FRNS on quality of life, strategies aiming to provide long-term remission while minimising treatment side eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Hogan, Julien, Perez, Aubriana, Sellier-Leclerc, Anne-Laure, Vrillon, Isabelle, Broux, Francoise, Nobili, Francois, Harambat, Jerome, Bessenay, Lucie, Audard, V, Faudeux, Camille, Morin, Denis, Pietrement, Christine, Tellier, Stephanie, Djeddi, Djamal, Eckart, Philippe, Lahoche, Annie, Roussey-Kesler, G, Ulinski, Tim, Boyer, Olivia, Plaisier, Emmanuelle, Cloarec, Sylvie, Jolivot, Anne, Guigonis, Vincent, Guilmin-Crepon, Sophie, Baudouin, Veronique, Dossier, Claire, Deschênes, Georges
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Renal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513594/
https://www.ncbi.nlm.nih.gov/pubmed/32967877
http://dx.doi.org/10.1136/bmjopen-2020-037306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513594/
https://www.ncbi.nlm.nih.gov/pubmed/32967877
http://dx.doi.org/10.1136/bmjopen-2020-037306

Ejemplares similares